Cripps advises Ortho Dev UK, part of Eqwal Group, on acquisition of Reed Medical (Holdings) Limited and trading subsidiary

Cripps has advised Ortho Dev UK Limited, part of the French-based Eqwal Group, on its acquisition of the entire issued share capital of Reed Medical (Holdings) Limited and its trading subsidiary Reed Medical Limited.

Reed Medical, based in the UK, specialises in the manufacture of orthopaedic and therapeutic footwear for individuals with diabetes, arthritis, and other complex foot conditions. The acquisition marks Eqwal Group’s continued expansion into the UK healthcare market and strengthens its European presence in the medical footwear sector.

Olivier Morel, Partner at Cripps, said:

We are delighted to have supported Ortho Dev and the Eqwal Group on this strategically important acquisition, the second deal of the past 18 months for our client. The transaction further demonstrates our ability to deliver seamless Franco-British legal advice and to guide clients through complex multi-jurisdictional deals within the healthcare and medical devices sector.”

The Cripps team advising Ortho Dev UK Limited was led by Olivier Morel, assisted by Erin Willock, Abigail Kirk, Phil Bilney, Jasprit Kaur, and Emily Byrom.

Forvis Mazars advised the buyer on financial matters, while Leonard Curtis Legal acted for the sellers.